GLP-2TZ [5MG]
$64.99
Available on backorder
Vials | Discount | |
---|---|---|
Bulk/tiered discount | 6 - 10 | 5% $61.74 |
Bulk/tiered discount | 11 - 15 | 10% $58.49 |
Bulk/tiered discount | 16 - 20 | 15% $55.24 |
Bulk/tiered discount | 21 + | 20% $51.99 |
Dual GIP/GLP-1 Receptor Agonist | Metabolic & Glucose Regulation Research | USA Manufactured & Third-Party Tested
Tirzepatide is a synthetic peptide currently being investigated for its dual agonist action on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-target mechanism makes it a compound of high interest in metabolic, glycemic, and weight regulation research.
Each 5mg vial of Tirzepatide is provided as a lyophilized powder to ensure stability, accuracy, and usability in laboratory environments. Manufactured in a cGMP-certified U.S. facility and third-party tested for >99% purity, this research-grade compound supports advanced studies into insulin sensitivity, appetite signaling, energy balance, and endocrine function.
Key Features
-
5mg lyophilized Tirzepatide per vial
-
Dual GIP and GLP-1 receptor agonist
-
USA-manufactured
-
Third-party tested for >99% purity and identity
-
Designed for research into metabolism, glucose homeostasis, and hormonal regulation
-
For research use only – not for human consumption
Disclaimer: This product is intended strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and is not for human use or consumption under any circumstances.
POPULAR PRODUCTS
Related products
-
NAD+ [500MG]
$119.99 -
Kisspeptin [10MG]
$49.99 -
GLP-2TZ [10MG]
$94.99